SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-020459
Filing Date
2016-06-09
Accepted
2016-06-09 17:10:48
Documents
115
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 20-F taro-20f_20160331.htm 20-F 5720991
2 EX-12.1 taro-ex121_256.htm EX-12.1 16377
3 EX-12.2 taro-ex122_257.htm EX-12.2 16299
4 EX-13 taro-ex13_255.htm EX-13 11058
  Complete submission text file 0001564590-16-020459.txt   17579976

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT taro-20160331.xml EX-101.INS 4190866
6 XBRL TAXONOMY EXTENSION SCHEMA taro-20160331.xsd EX-101.SCH 101880
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE taro-20160331_cal.xml EX-101.CAL 111012
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE taro-20160331_def.xml EX-101.DEF 264233
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE taro-20160331_lab.xml EX-101.LAB 667105
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE taro-20160331_pre.xml EX-101.PRE 526324
Mailing Address THREE SKYLINE DR HAWTHORNE NY 10532
Business Address 14 HAKTOR ST HAIFA BAY L3 26110 9143459001
TARO PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000906338 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-35463 | Film No.: 161706686
SIC: 2834 Pharmaceutical Preparations